Compare AVNW & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVNW | ALEC |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.0M | 262.7M |
| IPO Year | 2007 | 2019 |
| Metric | AVNW | ALEC |
|---|---|---|
| Price | $22.37 | $2.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $34.50 | $4.83 |
| AVG Volume (30 Days) | 208.5K | ★ 634.0K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $243,858,000.00 | $21,045,000.00 |
| Revenue This Year | $5.59 | $18.36 |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | $50.67 | ★ N/A |
| Revenue Growth | ★ 0.56 | N/A |
| 52 Week Low | $16.96 | $0.98 |
| 52 Week High | $27.02 | $3.40 |
| Indicator | AVNW | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 66.10 |
| Support Level | $20.86 | $1.89 |
| Resistance Level | $22.61 | $3.34 |
| Average True Range (ATR) | 1.16 | 0.19 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 74.66 | 96.68 |
Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.